
Berry Genomics (贝瑞和康)
Berry Genomics (贝瑞和康)
Claim
Berry Genomics (贝瑞和康) is a leading company in clinical genomics and life science in China. Berry Genomics is dedicated to research, development and commercialization of genetic test technologies in clinical applications. Berry Genomics aims to assist accurate diagnosis of diseases throughout the full human life circle, and to improve human health. As a company with strong R&D capability, Berry Genomics pioneered the first NGS-based genetic test, NIPT, in China back in 2010. The company currently Show MoreBerry Genomics (贝瑞和康) is a leading company in clinical genomics and life science in China. Berry Gen Show More
Alpha Score
$ 744.66 M
Alpha Score
76.8
Predictions
Overview
Team
Financials
- Partnerships
Relationships
Locations
Competitors
Comparison
News
Product
Regulatory
Clinical
Patent
Publications
Notes
0and0